FZD1 and gastric cancer: VIM antisense RNA 1 (VIM-AS1) expression enhanced tumorigenic pathways by downregulating miR-8052 expression and increasing expression of Fzd1 in human gastric cancer (GC) tissue (Sun et al., 2020).